Rights and permissions
About this article
Cite this article
HER-2 targeting is a potential approach for treating pancreatic cancer. Inpharma Wkly. 1310, 9 (2001). https://doi.org/10.2165/00128413-200113100-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200113100-00022